The Need for LIVESTRONG's Work Is Greater Now More Than Ever.
“With cancer survivorship expected to increase more than 35% over the next decade, the need for LIVESTRONG is greater now more than ever. Keep helping us fight the fight, the fight that impacts millions of lives each year. Together, we can and will change the way the world fights cancer.” – Greg Lee, LIVESTRONG President & CEO
For Darcy Doege, R.N., B.S.N., of the Levine Cancer Institute, finding cancer early in patients means hitting the road.
Darcy is the Program Coordinator for the Lung B.A.S.E.S. 4 Life Program for the Charlotte-based cancer center, which launched the first mobile lung screening unit in the U.S. in 2017. This innovative idea was built to increase the early detection of lung cancer for underserved populations across North and South Carolina, thanks to a grant from the Bristol-Myers Squibb Foundation
In Japan, Aflac insures 1 out of every 4 household, and Aflac Japan is proud to be the primary sponsor of “Gold Ribbon Walking” events, which the company supports to enhance the quality of life for children with cancer and improving the cure rate.
What a great way to raise awareness for childhood cancer and bring the community together in a big way!
As Pfizer celebrates 15 years of skills-based volunteering through its Global Health Fellows and Teams volunteer programs, which deploy colleagues around the world to work with international development organization partners through long- and short-term assignments, a team member reflects on the impact the program had on his life.
Company provides customers with an in-store opportunity to honor and support family and friends affected by cancer
WOONSOCKET, R.I., August 2, 2018 /3BL Media/ –CVS Health (NYSE: CVS) today announced a pledge to contribute a minimum of $10 million to the American Cancer Society through in-store fundraising over the next three years and to serve as the official retail pharmacy partner of the nation’s largest voluntary health organization dedicated to eliminating cancer.
Pfizer’s advances in oncology demonstrate the Power of Scientific innovation to help improve lives, particularly the power of Immuno-oncology (I-O). Immuno-oncology uses the natural ability of the body’s immune system to recognize and fight tumors. This past year, Pfizer continued to advance its work in I-O because we recognize the urgency of finding anti-cancer alternatives to help patients who need them.